Yu Jiangquan, Zheng Ruiqiang, Lin Hua, Chen Qihong, Shao Jun, Wang Daxin
Department of Intensive Care Unit, Northern Jiangsu People's Hospital, Yangzhou 225000, Jiangsu, China.
Department of Intensive Care Unit, Northern Jiangsu People's Hospital, Yangzhou 225000, Jiangsu, China.
Am J Emerg Med. 2017 Jan;35(1):101-105. doi: 10.1016/j.ajem.2016.10.015. Epub 2016 Oct 8.
This study aimed to investigate the clinical effects of early goal-directed therapy according to the global end-diastolic volume index (GEDI) on chronic obstructive pulmonary disease (COPD) patients with septic shock.
A total of 71 COPD patients with septic shock were randomly assigned to 2 groups. In the control group (n = 37), fluid resuscitation was performed based on the central venous pressure. In the study group (n = 34), fluid resuscitation was performed until GEDI reached 800 mL/m. The following indices were observed for the 2 groups: 6- and 24-hour fluid volumes, norepinephrine dosage, 24-hour blood lactate clearance rate, duration of mechanical ventilation, intensive care unit (ICU) length of stay, ICU mortality, and 90-day survival rate.
At both 6- and 24-hour measurements, the fluid volume was lower and norepinephrine dosage was higher in the control group than in the study group (P < .05). The blood lactate clearance rate was lower, the duration of mechanical ventilation was longer, and the length of stay in the ICU was longer in the control group than in the study group (P < .05). No significant difference in mortality or 90-day survival rate was found between the 2 groups.
The GEDI goal-directed fluid resuscitation shows better clinical effects than that shown by central venous pressure for COPD patients with septic shock; however, it cannot reduce the mortality rate.
本研究旨在探讨根据全心舒张末期容积指数(GEDI)进行早期目标导向治疗对慢性阻塞性肺疾病(COPD)合并感染性休克患者的临床效果。
将71例COPD合并感染性休克患者随机分为两组。对照组(n = 37)基于中心静脉压进行液体复苏。研究组(n = 34)进行液体复苏直至GEDI达到800 mL/m。观察两组的以下指标:6小时和24小时的液体量、去甲肾上腺素用量、24小时血乳酸清除率、机械通气时间、重症监护病房(ICU)住院时间、ICU死亡率和90天生存率。
在6小时和24小时测量时,对照组的液体量均低于研究组,而去甲肾上腺素用量高于研究组(P < 0.05)。对照组的血乳酸清除率较低,机械通气时间较长,ICU住院时间也比研究组长(P < 0.05)。两组之间的死亡率或90天生存率无显著差异。
对于COPD合并感染性休克患者,GEDI目标导向的液体复苏比基于中心静脉压的液体复苏显示出更好的临床效果;然而,它不能降低死亡率。